Brian Goodman, CEO of Golden Matrix Group Inc. explains how they stay one step ahead of their rivals. Watch the interview here.

Less Ads, More Data, More Tools Register for FREE
Sponsored Content
Sponsored Content

Pin to quick picksTarget Healthc. Regulatory News (THRL)

Share Price Information for Target Healthc. (THRL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 87.50
Bid: 87.10
Ask: 87.50
Change: 0.50 (0.57%)
Spread: 0.40 (0.459%)
Open: 87.20
High: 87.50
Low: 87.20
Prev. Close: 87.00

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Completion of Portfolio Acquisition

20 Dec 2021 07:00

RNS Number : 1175W
Target Healthcare REIT PLC
20 December 2021
 

20 December 2021

Target Healthcare REIT plc and its subsidiaries

("Target Healthcare" or "the Group")

 

Completion of 18-care home portfolio acquisition; total investment in quarter of £173 million; new £63 million long-term, fixed-rate loan facility

Target Healthcare (LSE: THRL), the UK listed specialist investor in modern, purpose-built care homes, announces that it has completed the acquisition of a major portfolio of 18 operational modern care homes. Combined with the previously noted acquisition of a pre-let development site in Weymouth, the Group's total investment during the quarter has been £173 million including costs. The acquisition yields are representative of assets of a similar standard and location within the Group's portfolio, and the properties benefit from long-term occupational leases with RPI-linked caps and collars.

These acquisitions, which formed part of the pipeline of acquisitions announced as part of the Company's recent £125 million equity fund raise, take the Group's portfolio to 98 assets and to 32 tenants once the development site becomes operational in June 2022.

Portfolio of 18 operational care homes

Target Healthcare has completed the acquisition of a major portfolio of 18 operational care homes, representing in excess of 1,200 beds. The Investment Manager has unparalleled knowledge of the individual assets within the portfolio, having sourced 17 out of the 18 care homes on behalf of the vendor, as well as having provided asset management services over the past 11 years.

The portfolio generates annual contracted rent of £9.2 million and has collected 100 per cent. of rent throughout the pandemic. This is a high-quality real estate portfolio, with an average age of approximately eleven years. All of the properties are purpose-built care homes with modern facilities including 100 per cent. en suite provision, the vast majority of which (96 per cent.) benefit from full wet-rooms. The portfolio is spread across eight tenants, three of which are new to the Group, including national operator, Barchester Healthcare, as well as two regional operators.

The properties each benefit from long-term occupational leases with RPI-linked caps and collars, with a weighted average unexpired lease term of approximately 22 years. The commercial terms of each of the occupational leases are consistent with equivalent leases in place across the Group.

Development site in Weymouth

The development is being undertaken by one of the UK's leading care home developers, LNT Group, and upon reaching practical completion the care home will be leased to experienced, regional operator, Chanctonbury Healthcare, on a 35-year, full repairing and insuring lease. Chanctonbury Healthcare will represent a new tenant to the Group.

Work on site has already commenced and practical completion is expected to be reached in June 2022. The development is being undertaken on a fixed price contract with the developer and, in line with previous forward funding agreements, the Group will earn interest on capital deployed through the construction phase.

Long-term institutional debt facility

The Company has completed a £63 million committed term loan facility (the "Facility") with Phoenix Group ("Phoenix"), an existing lending partner, utilising the full £100 million of new facilities which had been allocated and in diligence. The Facility carries an aggregate fixed rate of interest of 3.138% per annum on a 15-year term, maturing in January 2037.

Following the drawdown of the Facility, which is being used to finance the acquisitions and temporarily repay a portion of the Group's revolving credit facilities, the Group will have a net LTV of 21%; a weighted average term to maturity of its debt facilities of 7.5 years; and a weighted average cost of drawn debt, inclusive of amortisation of arrangement costs, of 3.08%.

The Group has undrawn flexible debt facilities of £97 million which will be used to fund portfolio commitments and the acquisition pipeline, to which the Group's investible capital is allocated.

The Group's total borrowing capacity now stands at £320 million comprising the Facility, the existing £87 million Phoenix facilities repayable in 2032 and existing facilities with The Royal Bank of Scotland plc (£70 million committed term loan and revolving credit facility repayable in 2025) and HSBC plc (£100 million revolving credit facility repayable towards the end of 2024).

John Flannelly, Head of Investment at Target Fund Managers, commented:

"We are pleased to have deployed the proceeds of the recent equity issuance so quickly, whilst agreement of the new 15-year term facility, the longest duration yet, will support us in our objective to provide stable returns to shareholders with long-term fixed interest costs matched against the inflation-linked long income that is generated from our portfolio.

"The acquisition of the 18-care home portfolio increases the size of the Group's existing portfolio by approximately 20 per cent and demonstrates the Group's ability to undertake transactions of scale. The quality of the real estate, combined with the diversified nature of the tenant base and the attractive pricing, underpins our investment thesis for this acquisition.

"On completion next year, the Weymouth asset will be a best-in-class care home in a location which demonstrates favourable demographics, whilst we are also pleased to be further diversifying our tenant base by partnering with a new, experienced operator in Chanctonbury Healthcare.

"These two transactions are strongly aligned with the Group's strict investment criteria as we continue our highly disciplined approach to the deployment of capital. We have a number of other transactions at advanced stages of due diligence and expect to be in a position to make further announcements in due course."

 

All enquiries:

Kenneth MacKenzie / John Flannelly / Gordon Bland

Target Fund Managers

 

01786 845 912

 

Mark Young / Mark Bloomfield

Stifel Nicolaus Europe Limited

 

020 7710 7600

 

Dido Laurimore / Claire Turvey / Richard Gotla

FTI Consulting

020 3727 1000

targethealthcare@fticonsulting.com

 

 

 

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the UK version of the Market Abuse Regulations (EU) No. 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended. Upon the publication of this announcement via Regulatory Information Service, this inside information is now considered to be in the public domain.

 

Notes to editors:

UK listed Target Healthcare REIT plc (THRL) is an externally managed Real Estate Investment Trust which provides shareholders with an attractive level of income, together with the potential for capital and income growth, from investing in a diversified portfolio of modern, purpose-built care homes.

The Group's portfolio at 30 September 2021 comprised 79 assets let to 28 different tenants with a total value of £702.7 million.

The Group only invests in modern, purpose-built care homes that are let to high quality tenants who demonstrate strong operational capabilities and a strong care ethos. The Group builds collaborative, supportive relationships with each of its tenants as it believes working in this way helps raise standards of care and helps its tenants build sustainable businesses. In turn, that helps the Group deliver stable returns to its investors.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQFFIFUUEFSEDE
Date   Source Headline
10th Dec 20247:00 amRNSResult of AGM
23rd Oct 202410:00 amRNSAnnual Financial Report
18th Sep 20247:00 amRNSInvestor Presentation via Investor Meet Company
17th Sep 20247:00 amRNSFinal Results
12th Sep 20249:00 amRNSNotice of Full Year Results
27th Jun 20247:00 amRNSDisposal of four care homes for £44.5 million
20th May 202412:09 pmEQSEdison issues update on Target Healthcare REIT (THRL): Positive momentum continued in Q3
28th Mar 20242:30 pmRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSHalf-year Report
8th Mar 20249:00 amRNSInvestor Presentation via Investor Meet Company
22nd Feb 20247:00 amRNSNotice of Half Year Results
6th Feb 20242:00 pmEQSEdison issues update on Target Healthcare REIT (THRL): Rent cover at a high and fully covered DPS
30th Nov 20237:00 amRNSResult of AGM
7th Nov 202310:16 amEQSEdison issues outlook on Target Healthcare REIT (THRL): DPS growth from a sustainable base
31st Oct 20235:30 pmRNSAnnual Financial Report
10th Oct 20237:00 amRNSFinal Results
4th Oct 20232:00 pmRNSNotice of Full Year Results
11th Aug 20238:09 amRNSEdison issues update on Target Healthcare REIT
28th Mar 202311:37 amRNSDirector/PDMR Shareholding
27th Mar 20237:00 amRNSHalf-year Report
27th Mar 20237:00 amRNSDisposal of four care homes in Northern Ireland
23rd Mar 20237:00 amRNSNotice of Half Year Results
17th Feb 202311:08 amRNSHolding(s) in Company
7th Dec 20227:00 amRNSDirectorate Change
6th Dec 20222:30 pmRNSResult of AGM
21st Nov 20225:07 pmRNSHolding(s) in Company
21st Nov 20227:00 amRNSHolding(s) in Company
21st Nov 20227:00 amRNSHolding(s) in Company
8th Nov 20225:47 pmRNSAnnual Financial Report
28th Oct 20229:17 amRNSHolding(s) in Company
17th Oct 20229:20 amRNSHolding(s) in Company
12th Oct 20227:00 amRNSFinal Results
12th Oct 20227:00 amRNSDirectorate Change
1st Sep 20227:00 amRNSPortfolio Update
22nd Jun 20227:00 amRNSHolding(s) in Company
9th Jun 20226:01 pmRNSHolding(s) in Company
9th Jun 20227:00 amRNSInclusion in FTSE 250 Index
6th Jun 20229:42 amRNSHolding(s) in Company
9th May 202211:43 amRNSDirector/PDMR Shareholding
5th May 202210:01 amRNSHolding(s) in Company
3rd May 20229:21 amRNSHolding(s) in Company
16th Mar 20227:00 amRNSHalf-year Report
10th Mar 20227:00 amRNSNotice of Half Year Results
1st Feb 20227:00 amRNSDirectorate Change
20th Dec 20217:00 amRNSCompletion of Portfolio Acquisition
15th Dec 20217:00 amRNSResult of AGM
30th Nov 20217:00 amRNSNew long-term institutional debt facility
10th Nov 20219:00 amRNSAnnual Financial Report
20th Oct 20217:00 amRNSFinal Results
18th Oct 20217:00 amRNSNotice of Full Year Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Free Investment Tools

Register for FREE

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.